Search

everythinglearnresearchcommunity

for

Search:↓

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Specialized techniques are needed for hair restoration in individuals with curly Afrocentric hair due to unique challenges.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

The Mona Lisa's high forehead and sparse eyebrows might be due to a hair loss condition or Renaissance fashion trends, but the actual reason is unknown.

Fat tissue and a specific protein are crucial for healthy hair growth and maintenance.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Portraits show women's hairlines have moved forward over time, suggesting changes in the occurrence of frontal hair loss.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.

Lichen planopilaris should be considered when diagnosing hair loss in people with darker skin as it may be often missed.

Biphasic alopecia often leads to permanent hair loss and its progression varies widely among individuals.

The microbiome may be linked to hair loss and could be a target for new treatments.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Naltrexone shows promise as a safe treatment for a type of hair loss called lichen planopilaris.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Not all hair loss patients need lab tests; patient history and physical exams are key to deciding who does.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Topical eye β-blockers may cause hair loss.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

In 2005, hair transplants looked natural and worked best with realistic goals, medication to preserve hair, and depended on the amount of donor hair.

Treatment with benzylpenicillin and prednisolone cured the patient's syphilis and hair loss.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.